# Nova Leap Health Stock Filter Stocks by Fundamentals

NLH Stock | CAD 0.24 0.01 4.35% |

Nova Leap Health fundamentals help investors to digest information that contributes to Nova Leap's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Leap's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Leap stock.

Nova | Shares Owned by Insiders |

## Nova Leap Current Valuation Drivers

We derive many important indicators used in calculating different scores of Nova Leap from analyzing Nova Leap's financial statements. These drivers represent accounts that assess Nova Leap's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nova Leap's important valuation drivers and their relationship over time.

2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||

Market Cap | 19.9M | 38.3M | 35.9M | 14.3M | 12.9M | 14.3M | |

Enterprise Value | 24.0M | 41.5M | 40.3M | 17.0M | 15.3M | 16.4M |

## Nova Fundamentals

Return On Equity | 0.0068 | ||||

Return On Asset | 0.0277 | ||||

Profit Margin | 0 % | ||||

Operating Margin | 0.04 % | ||||

Current Valuation | 20.81 M | ||||

Shares Outstanding | 86.21 M | ||||

Shares Owned By Insiders | 40.76 % | ||||

Number Of Shares Shorted | 316 | ||||

Price To Book | 0.83 X | ||||

Price To Sales | 0.80 X | ||||

Revenue | 26.41 M | ||||

Gross Profit | 9.98 M | ||||

EBITDA | 1.29 M | ||||

Net Income | (1.07 M) | ||||

Cash And Equivalents | 1.24 M | ||||

Cash Per Share | 0.02 X | ||||

Total Debt | 3.97 M | ||||

Debt To Equity | 64.80 % | ||||

Current Ratio | 0.58 X | ||||

Book Value Per Share | 0.21 X | ||||

Cash Flow From Operations | 1.41 M | ||||

Short Ratio | 0.01 X | ||||

Earnings Per Share | (0.02) X | ||||

Target Price | 0.6 | ||||

Beta | 1.52 | ||||

Market Capitalization | 20.69 M | ||||

Total Asset | 23.95 M | ||||

Retained Earnings | (1.19 M) | ||||

Working Capital | (10.37 K) | ||||

Net Asset | 23.95 M |

## About Nova Leap Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.
## Thematic Opportunities

### Explore Investment Opportunities

## Additional Tools for Nova Stock Analysis

When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.